J Dorey - Concepedia

Author

J Dorey

Creativ-Ceutical (France)ORCID

Also Known As

J Dorey, J. Dorey, J. Griffith, J. MILNOR DOREY, J. Milnor Dorey, Julie Dorey

Publications

564

Citations

H-Index

Concepts

All Affiliations

Creativ-Ceutical (France)Aix-Marseille Université Université Claude Bernard Lyon 1 Istituto Neurologico Mediterraneo

About

J Dorey is an author at Creativ-Ceutical (France) specializing in medicine, quality of life, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	75
2	Geriatrics	2	2	28
3	Neurology	2	2	28
4	Psychiatry	2	2	63
5	Health Sciences	1	1	47

J Dorey

Publications

440

Citations

H-Index

Page 1

	Year	Citations
Key drivers for market penetration of biosimilars in Europe C. Rémuzat, J Dorey, Olivier Cristeau, Journal of Market Access & Health Policy	2017	211
Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder Amandine Luquiens, Diane Whalley, SR Crawford, Quality of Life Research Quality Of LifeSubstance AbuseAlcohol MisuseSubstance UseAlcohol Quality	2014	47
Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey Ataru Igarashi, Ayako Fukuda, Lida Teng, Journal of Market Access & Health Policy	2020	42
Health‐care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis Atsuyuki Igarashi, Hiroyuki Fujita, Kazuhiko Arima, The Journal of Dermatology	2019	33
The quality of life of Spanish patients with Huntington's disease measured with H-QoL-I and EQ-5D J Dorey, E. Clay, Amine Khemiri, Journal of Market Access & Health Policy	2016	19
Responder and health‐related quality of life analyses in men with lower urinary tract symptoms treated with a fixed‐dose combination of solifenacin and tamsulosin oral‐controlled absorption system: results from the NEPTUNE study Marcus J. Drake, Roman Sokol, Karin S. Coyne, British Journal of Urology	2015	17
Validation of the first quality-of-life measurement for patients with Huntington’s disease E. Clay, Annunziata De Nicola, J Dorey, International Clinical Psychopharmacology Palliative CareQuality Of LifeLife InstrumentLife AssessmentHuntington ’	2012	16
The Progressive Education Association J Dorey Childhood Education	1929	15
Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population Mondher Toumi, A. Millier, Olivier Cristeau, Frontiers in Medicine	2020	15
Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data C. François, Robert A. Hauser, Samuel Aballéa, Journal of Medical Economics	2015	13

Page 1